Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Rovi Pharmaceuticals Laboratories

Clinical trials sponsored by Rovi Pharmaceuticals Laboratories, explained in plain language.

Not yet recruiting 2 Not yet finished but already full! 1 Completed 2
Sort by
  • New injectable treatment shows promise for schizophrenia relapse

    Disease control Completed

    This study looked at how well Risperidone ISM works for people with schizophrenia who were hospitalized after a relapse. Researchers tracked 275 patients over 56 days to see if their symptoms improved and if they could better manage daily life. The treatment is given as an inject…

    Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control

    Last updated Jun 27, 2026 08:02 UTC

  • Schizophrenia treatment could go from daily pills to four shots a year

    Disease control Completed

    This early-phase study tested a new long-acting injection of the antipsychotic drug risperidone that would only need to be given once every three months. Fifty-eight adults with stable schizophrenia received a single shot at different doses to measure how the drug moves through t…

    Phase: PHASE1 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control

    Last updated Jun 26, 2026 15:04 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space